These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31142340)

  • 1. FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer.
    Piasecka D; Braun M; Kitowska K; Mieczkowski K; Kordek R; Sadej R; Romanska H
    J Exp Clin Cancer Res; 2019 May; 38(1):230. PubMed ID: 31142340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGFR signalling in women's cancers.
    Fearon AE; Gould CR; Grose RP
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer.
    Francavilla C; O'Brien CS
    Open Biol; 2022 Feb; 12(2):210373. PubMed ID: 35193394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer.
    Diep CH; Spartz A; Truong TH; Dwyer AR; El-Ashry D; Lange CA
    Endocrinology; 2024 Jul; 165(9):. PubMed ID: 39041201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGFR-targeted therapeutics for the treatment of breast cancer.
    De Luca A; Frezzetti D; Gallo M; Normanno N
    Expert Opin Investig Drugs; 2017 Mar; 26(3):303-311. PubMed ID: 28121208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and challenges in targeting FGFR signalling in cancer.
    Babina IS; Turner NC
    Nat Rev Cancer; 2017 May; 17(5):318-332. PubMed ID: 28303906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?
    Bedussi F; Bottini A; Memo M; Fox SB; Sigala S; Generali D
    Expert Opin Ther Targets; 2014 Jun; 18(6):665-78. PubMed ID: 24833241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer.
    Shee K; Yang W; Hinds JW; Hampsch RA; Varn FS; Traphagen NA; Patel K; Cheng C; Jenkins NP; Kettenbach AN; Demidenko E; Owens P; Faber AC; Golub TR; Straussman R; Miller TW
    J Exp Med; 2018 Mar; 215(3):895-910. PubMed ID: 29436393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments and advances of FGFR as a potential target in cancer.
    Xue WJ; Li MT; Chen L; Sun LP; Li YY
    Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights in the Interaction of FGF/FGFR and Steroid Receptor Signaling in Breast Cancer.
    Pérez Piñero C; Giulianelli S; Lamb CA; Lanari C
    Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34977930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for targeting fibroblast growth factor receptor signaling in breast cancer.
    André F; Cortés J
    Breast Cancer Res Treat; 2015 Feb; 150(1):1-8. PubMed ID: 25677745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
    Cerliani JP; Guillardoy T; Giulianelli S; Vaque JP; Gutkind JS; Vanzulli SI; Martins R; Zeitlin E; Lamb CA; Lanari C
    Cancer Res; 2011 May; 71(10):3720-31. PubMed ID: 21464042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
    Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
    J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the fibroblast growth factor receptor family in cancer.
    Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
    Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De-regulated FGF receptors as therapeutic targets in cancer.
    Knights V; Cook SJ
    Pharmacol Ther; 2010 Jan; 125(1):105-17. PubMed ID: 19874848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibition of fibroblast growth factor receptors in cancer.
    Liang G; Chen G; Wei X; Zhao Y; Li X
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting FGFR with BGJ398 in Breast Cancer: Effect on Tumor Growth and Metastasis.
    Sahores A; May M; Sequeira GR; Fuentes C; Jacobsen B; Lanari C; Lamb CA
    Curr Cancer Drug Targets; 2018; 18(10):979-987. PubMed ID: 29237381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
    Hierro C; Rodon J; Tabernero J
    Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.